News & Updates

Patients with inflammatory bowel disease (IBD) can switch from intravenous to subcutaneous vedolizumab treatment in the maintenance setting, with the clinical and biochemical disease activity remaining stable after the change, as shown in a study. However, some patients switch back to intravenous treatment due to adverse events or fear of needles.

Oxycodone delivery via intravenous patient-controlled analgesia (IVPCA) allows women to self-administer analgesics when experiencing pain during medical abortion, helping reduce pain to mild or tolerable levels, according to a study.

Women who are stressed have a habit of eating away from home, but the effects tend to be very minimal, according to a China study.

PartnerCARE, an online intervention designed to address mental health needs of caregiving partners of cancer patients, appears to be feasible and acceptable, a recent study has found. PartnerCARE also appears to be effective, inducing substantial improvements in psychological distress and anxiety.

A large proportion of cancer patients suffering from depressive symptoms cannot seem to effectively manage this burden on their own, particularly those who tend to avoid dealing with their own problems, reports a recent analysis.

New drug applications approved by US FDA as of 16 - 31 July 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.